Methods of treating diseases in association with decrease in the expression of AOP-1 gene or AOP-1 and remedies for the diseases

Details for Australian Patent Application No. 2002233643 (hide)

Owner Asubio Pharma Co., Ltd.

Inventors Sugimura, Keijiro; Hattori, Fumiyuki; Furuya, Mayumi

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002233643

PCT Pub. Number WO2002/064169

Priority 2001-41003 16.02.01 JP

Filing date 18 February 2002

Wipo publication date 28 August 2002

Acceptance publication date 26 July 2007

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61K 31/711 (2006.01) - Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links

A61K 38/08 (2006.01) Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 38/44 (2006.01) Medicinal preparations containing peptides

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 9/02 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C12N 9/02 (2006.01) Enzymes, e.g. ligases (6.) - Oxidoreductases (1.), e.g. luciferase

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

20 February 2003 Application Open to Public Inspection

  Published as AU-B-2002233643

19 May 2005 Assignment before Grant

  Suntory Limited; Daiichi Suntory Biomedical Research Ltd. The application has been assigned to Suntory Limited; Daiichi Suntory Pharma Co., Ltd

19 January 2006 Change of Name(s) of Applicant(s), Section 104

  Daiichi Suntory Pharma Co., Ltd. The name of the applicant has been changed to Daiichi Asubio Pharma Co., Ltd.

24 May 2007 Change of Name(s) of Applicant(s), Section 104

  Daiichi Asubio Pharma Co., Ltd. The name of the applicant has been changed to Asubio Pharma Co., Ltd.

26 July 2007 Application Accepted

  Published as AU-B-2002233643

22 November 2007 Standard Patent Sealed

13 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002233644-Radiation sensitive refractive index changing composition

2002233642-MARINE GROWTH PREVENTIVE AGENT